Adrian J. Mogg
Salisbury, ENG SP40BF, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein.
Journal: ACS medicinal chemistry letters
Published: December 21, 2023
Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs.
Journal: Nature chemical biology
Published: June 12, 2019
PET ligands [18F]LSN3316612 and [11C]LSN3316612 quantify O-linked-β-N-acetyl-glucosamine hydrolase in the brain.
Journal: Science translational medicine
Published: July 06, 2018
Identification and pharmacological profile of SPP1, a potent, functionally selective and brain penetrant agonist at muscarinic M1 receptors.
Journal: British journal of pharmacology
Published: March 13, 2018
In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography.
Journal: The Journal of pharmacology and experimental therapeutics
Published: November 18, 2017
Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases.
Journal: Neuropharmacology
Published: July 07, 2017
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss.
Journal: The Journal of clinical investigation
Published: March 11, 2016
Activation of Muscarinic M1 Acetylcholine Receptors Induces Long-Term Potentiation in the Hippocampus.
Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: October 17, 2015
Activation of transient receptor potential ankyrin 1 induces CGRP release from spinal cord synaptosomes.
Journal: Pharmacology research & perspectives
Published: August 04, 2015
An Antibody Biosensor Establishes the Activation of the M1 Muscarinic Acetylcholine Receptor during Learning and Memory.
Journal: The Journal of biological chemistry
Published: July 29, 2015
Last Updated: 09/26/2026